FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/07/2024
Back to search
Official data from USPTO
BRENUS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/07/2024
Trademark type
Combined
Nice classes
5
Filing date
09/19/2022
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FR
Examiner
WOLD, BARBARA
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two intersecting blue stylized triangles to the left of the blue stylized wording "BRENUS PHARMA". The background in white is not claimed as a feautre of the mark.
Holders and representatives
Holders
B. P. (pessoa física)
Representatives
Pina Campagna Carter, DeLuca, and Farrell, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of cancerviral and bacterial diseases; chemical preparations for medical usefor the treatment of cancerviral and bacterial diseases; chemical preparations for pharmaceutical usefor the treatment of cancerviral and bacterial diseases; biological preparations for medical or therapeutic usebiological preparations for the treatment of cancerviral and bacterial diseases; chemical-pharmaceutical preparationschemical preparations for the treatment of cancerviral and bacterial diseases; medicines for human medicinemedicines for the treatment of cancerviral and bacterial diseases; biocellular preparations being human cells for therapeutic or medical use; pharmaceutical immunostimulants
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/12/2024
FIMP
FINAL DISPOSITION PROCESSED
04/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/24/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2023
PUBO
PUBLISHED FOR OPPOSITION
10/24/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/15/2023
RFNT
REFUSAL PROCESSED BY IB
08/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2023
RFRR
REFUSAL PROCESSED BY MPU
08/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/23/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/04/2023
CNRT
NON-FINAL ACTION WRITTEN
07/03/2023
DOCK
ASSIGNED TO EXAMINER
06/29/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2022
Continuous trademark protection
Get notified about every new filing that threatens BRENUS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.